Webinars

Register >> July 17, 2025 3PM CEST The European pharmaceutical landscape presents complex challenges in meeting Post-Authorization Safety Study (PASS) obligations and Health Technology Assessment (HTA) requirements. Successfully navigating these evolving regulations, especially with the implementation of the EU HTA Regulation, is crucial for sustained market access and demonstrating ongoing product value. Designed for pharmaceutical[…]

Register >> June 26, 2025 2:30pm ET Mental health conditions can take a significant toll on an individual—physically, socially, and financially. Despite new treatment options becoming available, many patients still continue to struggle with finding effective solutions. Frustratingly, even treatments with strong efficacy won’t work for everyone – and it’s very hard to know in advance[…]

Register >> Thursday, May 8, 2025 | 12:00-1:00PM EST As drug development becomes more complex and personalized, traditional randomized controlled trials (RCTs) are no longer sufficient to answer every research question—particularly in rare diseases, and situations lacking head-to-head comparisons. Regulators, payers and other stakeholders are increasingly turning to real-world evidence (RWE) to address the gaps,[…]

FiercePharma Register >> April 8, 2025 1:00PM – 2:00PM EST Traditional commercial strategies focus on known patient populations— but what about patients who aren’t on the radar? AI-powered digital phenotyping and real-world data (RWD) offer new ways to locate overlooked patient populations, identify gaps between clinical guidelines and real-world treatment patterns, and optimize market positioning[…]

Register >> Friday, January 10th 2025 10:00 – 11:00 AM EST Webinar Synopsis Join us as we delve into the groundbreaking partnership between OM1 and Exact Sciences in the Falcon Registry Real-World Evidence (RWE) study. This ambitious initiative aims to enroll 25,000 patients across diverse backgrounds to evaluate the clinical impact of Multi-Cancer Early Detection[…]